Muscle-invasive bladder cancer treated with external beam radiation: Influence of total dose, overall treatment time, and treatment interruption on local control

International Journal of Radiation Oncology Biology Physics

Volumn 42, Issue 3, 1998, Pages 525-530

  Moonen, L ^a   Voet, H V D ^a   De Nijs, R ^a   Horenblas, S ^a   Hart, A A M ^a   Bartelink, H ^a  

^a NETHERLANDS CANCER INSTITUTE   (Netherlands)

Author keywords

Bladder cancer; Radiotherapy; Treatment time; Tumor proliferation

Indexed keywords

ADULT; AGED; ARTICLE; BEAM THERAPY; BLADDER CANCER; CANCER INVASION; CANCER RECURRENCE; CELL PROLIFERATION; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; OUTCOMES RESEARCH; PRIORITY JOURNAL; PROGNOSIS; RADIATION DOSE;

AGED; AGED, 80 AND OVER; CARCINOMA, TRANSITIONAL CELL; CELL DIVISION; FEMALE; HUMANS; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM INVASIVENESS; NEOPLASM RECURRENCE, LOCAL; RADIOTHERAPY DOSAGE; URINARY BLADDER NEOPLASMS;

EID: 0031785195     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(98)00263-6     Document Type: Article

References (27)

1. 50, and dose-time prescription habits in radiotherapy of head and neck tumours. Radiother Oncol 1994;32:197-200.
2. Fowler JF, Tanner MA, Bataini JP, Asselain B, Bernier J, Lave C. Further analysis of the time factor in squamous cell carcinoma of the tonsillar region. Radiother Oncol 1990;19: 237-244.
3. Lanciano RM, Pajak TF, Martz K, Hanks G. The influence of treatment time on outcome for squamous cell cancer of the uterine cervix treated with radiation: A patterns-of-care study. Int J Radiat Oncol Biol Phys 1993;25:391-397.
4. Maciejewski B, Withers HR, Taylor JMG, Hliniak A. Dose fractionation and regeneration in radiotherapy for cancer of the oral cavity and ororpharynx: Tumor dose response and repopulation. Int J Radiat Oncol Biol Phys 1989;16:831-843.
5. Van Putten WLJ, Van der Sangen MJC, Hoekstra CJM, Levendag PC. Dose, fractionation and overall treatment time in radiation therapy: The effects on local control for cancer of the larynx. Radiother Oncol 1994;30:97-108.
6. 3 laryngeal cancer using radiotherapy. Radiother Oncol 1992;24:215-220.
7. Taylor JMG, Wendenhall WM, Lavey RS. Time-dose factors in positive neck nodes treated with irradiation only. Radiother Oncol 1991;22:167-173.
8. Withers HR, Taylor JMG, Maciejewski B. The hazard of accelerated tumor clonogen repopulation during radiotherapy. Acta Oncol 1988;27:131-146.
9. Withers HR, Peters LJ, Taylor JMG, Owen JB, Morrison W, Schultheiss T, Keane T, O'Sullivan B, van Dijk J, Gupta N, Wang CC, Jones P, Doppke R, Myint S, Thompson M, Parsons J, Mendenhall W, Dische S, Aird J, Henk M, Bidmead M, Svoboda V, Chon Y, Hanlon A, Peters TL, Hanks GE. Local control of carcinoma of the tonsil by radiation therapy: An analysis of patterns of fractionation in nine institutions. Int J Radiat Oncol Biol Phys 1995;33:549-562.
10. Horiot JC, Bontemps P, Le Fur R, Van den Bogaert W, Bolla M, Van den Weijngaert D, Bernier J, Lusinchi A, Lopez Torrecilla D, Colette L, Pierart M. An overview of the EORTC accelerated and hyperfractionated radiotherapy trials in head and neck cancers. Radiother Oncol 1996;40:106 (abstract).
11. Overgaard J, Sand Hansen H, Sapru W, Overgaard M, Grau C, Jorgensen K, Basthold L, Hansen O, Specht L, Berthelsen A, Pedersen M, Evensen J. A randomized multicenter study of 5 versus 6 fractions per week as the primary treatment of squamous cell carcinoma of the head and neck. Preliminary results from the DAHANCA 6 and 7 trial. Radiother Oncol 1996;40: 110 (abstract).
12. Saunders MI, Dische S, Barret A, Parmar MK, Harvey A, Gibson D. Randomised multicentre trial of CHART versus conventional radiotherapy in head and neck and non-small-cell cancer: An interim report. Br J Cancer 1996;73:1455-1462.
13. Maciejewski B, Makewski S. Dose fractionation and tumor repopulation in radiotherapy for bladder cancer. Radiother Oncol 1991;21:163-170.
14. de Neve W, Lybeert MLM, Goor C, Crommelin M, Ribot JG. Radiotherapy for T2 and T3 carcinoma of the bladder: The influence of overall treatment time. Radiother Oncol 1995;36: 183-188.
15. Bentzen SM, Thames HD. Clinical evidence for tumor clonogen regeneration: Interpretations of the data. Radiother Oncol 1991;22:161-166.
16. Eifel PJ, Thames HD. Has the influence of treatment duration on local control of carcinoma of the cervix been defined? Int J Radiat Oncol Biol Phys 1995;32:1527-1529.
17. Wilson GD, Mc Nelly NJ, Dische S, Saunders MI, des Rochers C, Lewis AC, Bennet MH. Measurement of cell kinetics in human tumours using in vivo labelling with bromodeoxyuridine. Br J Radiol 1988;61:419-422.
18. Cox DR. Regression models and live tables. J R Statis Soc B 1972;34:187-220.
19. Schoenfeld D. Partial residuals from the proportional hazards regression models. Biometrika 1982;69:239-241.
20. Wright P. Adjusted P-values for simultaneous inference. Biometrics 1992;48:1005-1013.
21. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958;53:457-481.
22. Fyles A, Keane TJ, Barton M, Simm J. The effect of treatment duration in the local control of cervix cancer. Radiother Oncol 1992;25:273-279.
23. Girinski T, Rey A, Roche B, Haie C, Gerbaulet A, Randrianarivello H, Chassagne D. Overall treatment time in advanced cervical carcinomas: A critical parameter in treatment outcome. Int J Radiat Oncol Biol Phys 1993;27:1051-1056.
24. Morrison R. The results of treatment of cancer of the bladder - a clinical contribution to radiobiology. Clin Radiol 1975; 26:67-75.
25. Näslund I, Nilsson B, Littbrand B. Hyperfractionated radiotherapy of bladder cancer. A ten-year follow-up of a randomized clinical trial. Acta Oncol 1994;33:397-402.
26. Perez CA, Grigsby PW, Castro-Vita H, Lockett MA. Carcinoma of the urterine cervix. I. Impact of prolongation of overall treatment time and timing of brachytherapy on outcome of radiation therapy. Int J Radiat Oncol Biol Phys 1995;32:1275-1288.
27. Horwich A. Cancer Research Campaign Review of Radiobiology Research. Br J Cancer 1993;67:198-201.